secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vincerx Pharma, Inc. (—)
CIK:        0001796129
Form:       8-K
Filed at:   2025-04-17T23:59:59+00:00
Accession:  0001193125-25-084406
Event type: other_material
Sentiment:  negative
Materiality: 0.90
Item codes: 3.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vincerx Pharma to delist from Nasdaq, dissolve and liquidate; trading suspended Apr 23
--------------------------------------------------------------------------------

- Received Nasdaq delisting notice on Apr 14 due to bid price below $1 for 30 days; no compliance period available due to prior reverse stock split.
- Board unanimously approved plan of dissolution and liquidation on Apr 17, subject to stockholder approval.
- Will not appeal Nasdaq determination; intends to voluntarily delist and deregister via Form 25 (filing on/around Apr 28) and Form 15.
- Nasdaq inadvertently suspended trading on Apr 16; trading resumes Apr 21-22 before permanent suspension at open on Apr 23.
- No plans to list on another exchange; any assets remaining after creditors will be distributed to stockholders.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1796129/000119312525084406/0001193125-25-084406-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1796129/000119312525084406/d932920d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-084406

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer